The Drug Controller General of India (DCGI) on Friday granted the approval to the Serum Institute of India (SII) for the initial manufacture of the Russian COVID-19 vaccine Sputnik V for testing, examination, and analysis purposes with certain condit ...
Indian vaccine manufacturing company Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for the production of the Russian vaccine Sputnik V in India. ...
A man in Uttar Pradesh's Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in his bod ...
With ramping up of production capacities, nearly 25 crore 'Made in India' vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore people dail ...
With ramping up of production capacities, nearly 25 crore 'Made in India' vaccines are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore people daily aga ...
The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. ...
The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. ...
India's leading virologist Dr Gagandeep Kang has said that since the number of Covid-19 cases in the country has stabilized now, the number of deaths due to the virus will also stabilize soon and if it fails to do so then it can only point to an issu ...
